Channels - TNFR2-targeted nanoparticles for regulatory T-cell modulation in cancer immunotherapy: a narrative review :: FRELIP Discovery

Similar Items: TNFR2-targeted nanoparticles for regulatory T-cell modulation in cancer immunotherapy: a narrative review

Quick Look
Targeting cancer stem cells: advances in small molecules, biologics, and immunotherapies
Quick Look
Engineered immune cells and extracellular vesicles target tumour microenvironment barriers in solid tumour immunotherapy
Quick Look
Synergistic efficacy of radiotherapy and immunotherapy enhances clinical outcomes in patients with advanced non-small cell lung cancer
Quick Look
Identification of FMR1 as a novel cancer prognostic and immunotherapy biomarker through renal cancer experimental validation and pan-cancer analysis
Quick Look
A NEK2/ZWINT–NDC80 regulatory axis drives bladder cancer progression and chemoresistance
Quick Look
Cell-specific multi-target mechanisms of cotinine in cervical cancer oncogenesis and progression
Quick Look
Post-translational modifications in glioma immune evasion and immunotherapy resistance
Quick Look
Cancer-associated fibroblasts as a target in head and neck squamous cell carcinoma: bridging mechanisms to therapy with drugs, adjuvants, and nanotechnology
Quick Look
Integrated single-cell RNA sequencing and mendelian randomization reveals the role of resting regulatory T cells in skin melanoma prognosis
Quick Look
Sarcopenia and sarcopenic obesity in type 2 diabetes mellitus and cardiovascular disease: current perspective and narrative review
Quick Look
Differential expression of LYZ across pan-cancer and its prognostic value and immune microenvironment regulatory mechanisms in glioma
Quick Look
Pan cancer analyses and clinical cohort validation identify HOMER3 as colorectal cancer prognostic biomarker and therapeutic target
Quick Look
The influence of the secretome from human amniotic mesenchymal stem cells on p53 and MDM2 expression in MDA-MB-231 breast cancer cell line
Quick Look
Innovative strategies to overcome cancer drug resistance: from nanodelivery systems to targeted therapeutics
Quick Look
Neuroendocrine neoplasms of the oral cavity: a narrative review of clinicopathological features and management
Quick Look
The potential utility of in-silico approach in identifying phytochemicals against various targets for the management of lung cancer
Quick Look
Pan-cancer analysis identifies APOC1 as a TAM-derived modulator of adaptive immune resistance and predictor of therapeutic response
Quick Look
Desmoglein 2 is associated with dihydroartemisinin resistance in HeLa cervical cancer cells: a potential link to the PI3K/AKT signaling pathway
Quick Look
Integrated network pharmacology reveal new key curcumin-binding targets in triple-negative breast cancer
Quick Look
Identification of ZNF469 as a potential biomarker and therapeutic target for gastric cancer through integrated multi dataset analysis
Quick Look
Network toxicology and molecular docking identify BRCA1 as a functional target of the dietary carcinogen PhIP in colorectal cancer
Quick Look
Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer
Quick Look
Integrative analysis identifies ALDOA and PGK1 as prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma
Quick Look
Artificial intelligence and multi-omics revealed the authentic regulation of ADP-ribosylation in modulation Treg/Th17 ecosystem and multi-target therapeutic strategy enrichment for HBV+ Hepatocellular Carcinoma patients